VCYT
Veracyte, Inc.
stock NASDAQ

GH and NTRA have had several approvals/reimbursement wins this year. Not all that close to NEO or VCYT but it seems like their core businesses are humming.
TWST and ILMN are derivative plays on the industry so makes sense they'd be up too, though ILMN is more of a complicated product cycle/China story. MRVI is borderline special sits.
You're 100% right on the rates argument. But also if you're an institution its much easier to be long Dx vs core tools (typically grouped together) given valuations there and the constant head fake rebounds. Also assume people are starting to shift some money within HC out of biopharma after the YTD run, and Dx gives you some similar factor exposure.
Haven't seen much spec dx discussion on reddit since covid, good shit

GH and NTRA have had several approvals/reimbursement wins this year. Not all that close to NEO or VCYT but it seems like their core businesses are humming.
TWST and ILMN are derivative plays on the industry so makes sense they'd be up too, though ILMN is more of a complicated product cycle/China story. MRVI is borderline special sits.
You're 100% right on the rates argument. But also if you're an institution its much easier to be long Dx vs core tools (typically grouped together) given valuations there and the constant head fake rebounds. Also assume people are starting to shift some money within HC out of biopharma after the YTD run, and Dx gives you some similar factor exposure.
Haven't seen much spec dx discussion on reddit since covid, good shit